Successful Superficial Blood Sampling to Localize a Fibroblast Growth Factor-23-Producing Tumor

Junjiro Rikitake; Kenji Ashida; Ayako Nagayama; Yukihiro Inoguchi; Nao Hasuzawa; Masamichi Koganemaru; Tetsuya Hamada; Kanoko Moritaka; Mutsuyuki Demiya; Tomoki Sako; Jun Akiba; Koji Hiraoka; Masatoshi Nomura

doi:10.12659/AJCR.943152

13 April 2024 : Case report Japan

Successful Superficial Blood Sampling to Localize a Fibroblast Growth Factor-23-Producing Tumor

Challenging differential diagnosis, Unusual setting of medical care, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)

Junjiro Rikitake^1ABCDEF, Kenji Ashida

^1ABCDEF*, Ayako Nagayama^1ACDEF, Yukihiro Inoguchi^1CDEF, Nao Hasuzawa^1CDEF, Masamichi Koganemaru^2BCDE, Tetsuya Hamada^3BCDE, Kanoko Moritaka^1BCDE, Mutsuyuki Demiya^1BCDE, Tomoki Sako^1BCDE, Jun Akiba^4BCDE, Koji Hiraoka^3BCDE, Masatoshi Nomura^1ACDEF

DOI: 10.12659/AJCR.943152

Am J Case Rep 2024; 25:e943152

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References:

View HTML version

Figure 5. Octreotide scintigraphy and FDG scintigraphy. (A) FDG scintigraphy. (B, C) Octreotide scintigraphy. Abnormal accumulation in the left third basal phalanx (arrows) along with physiological accumulation manifested in the renal, urinary, and gastrointestinal systems. FDG – 18F-fluorodeoxyglucose.

Back to the Article

Successful Superficial Blood Sampling to Localize a Fibroblast Growth Factor-23-Producing Tumor

Your Privacy